Core Insights - The Chinese government is promoting the integration of artificial intelligence (AI) in healthcare, emphasizing the application of AI in various medical fields to enhance efficiency and service delivery [1][5]. Group 1: AI in Diagnostic Services - AI tools like the "DeepSeek" model are being utilized in hospitals to improve diagnostic efficiency, allowing doctors to analyze complex cases more quickly and accurately [2][3]. - Over 100 hospitals across more than 20 provinces in China have implemented the DeepSeek model, enhancing the overall management and operational efficiency of healthcare institutions [5]. Group 2: AI in Pediatric Healthcare - The "福棠·百川" pediatric AI model integrates the expertise of over 300 pediatric specialists and extensive clinical guidelines, improving diagnostic accuracy for common and rare pediatric diseases [4]. - The model supports personalized analysis and dynamic tracking of the latest research, aiming to reduce misdiagnosis and over-treatment risks [4]. Group 3: AI in Medical Devices - AI and augmented reality (AR) technologies are being applied in minimally invasive surgeries, such as lung nodule removal, significantly improving precision and reducing patient discomfort [6][7]. - Advanced imaging devices, like the intelligent CT scanner, utilize AI to optimize scanning processes and enhance diagnostic accuracy, particularly in primary healthcare settings [8]. Group 4: AI in Drug Development - AI is accelerating the drug development process, exemplified by a treatment for idiopathic pulmonary fibrosis that has shown promising clinical results, with AI reducing development time by two-thirds [10][11]. - The integration of AI tools throughout the drug development lifecycle is enhancing efficiency and reducing costs, with numerous AI-driven drug candidates currently in clinical trials [12]. Group 5: Future of AI in Healthcare - AI is viewed as a supportive tool for healthcare professionals, enhancing their capabilities rather than replacing them, allowing for more focus on complex medical tasks [13][14].

"AI+医疗"浪潮奔涌。2025年开年，DeepSeek的惊艳亮相，再度把"AI+医疗"拉回大众视野。从药企巨头到体外诊断新锐，从三甲医院到互联网医疗平台， 每个参与者都在用智能代码重构生命密码。在资本市场上，相关概念股走出傲人行情，有个股股价在一个多月间实现翻倍。只要与AI相关，势必会受到投 资者追捧。在机构看来，"AI+医疗"或将成为贯穿2025年全年的投资机会。 在2025年中关村论坛年会上，"AI+医疗"也将成为热点话题，脑机接口、基因治疗、激光质子刀、手术机器人等前沿技术创新成果将在期间亮相。此外，3 月29日，中关村论坛平行论坛——医学AI创新与发展论坛将在中关村国际创新中心举办，旨在全面推进AI技术在医疗行业的创新与发展。 li C 加速药物研发的钥匙 据悉，相较于传统药物研发，AI技术能将药物发现、临床前研究的时间缩短近40%，临床新药研发成功率可从12%提高到约14%。 英矽智能正是一家AI药物研发初创企业，在AI-Biotech的道路上走得相对较快。就在3月，英矽智能宣布，其自主研发的抗特发性肺纤维化创新候选药物 ISM001-055的通用名Rentosertib获美国药物命名委员会批准。 ...